ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,346.99
      -0.11%
      US Tech 100
      18,503.20
      -0.17%
      Dow Jones
      38,798.99
      -0.22%
      Brent Oil
      79.325
      -0.69%
      Bitcoin
      69,162.68
      -2.26%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Vir Biotechnology Inc (VIR)

      7. Vir Biotechnology Inc (VIR) News

      VIR

      Vir Biotechnology (VIR)

      Vir Biotechnology Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:VIR
      DateTimeSourceHeadlineSymbolCompany
      2:15PMiHub NewswireFeaturedDaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio
      06/05/20246:04AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VIRVir Biotechnology Inc
      06/05/20245:30AMBusiness WireTobevibart Monotherapy and Combination Therapy with Elebsiran Achieved High Virologic Response and ALT Normalization in People Living with the Hepatitis Delta Virus After 12 and 24 Weeks of TreatmentNASDAQ:VIRVir Biotechnology Inc
      06/03/202412:13PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VIRVir Biotechnology Inc
      06/03/202411:57AMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VIRVir Biotechnology Inc
      05/31/20242:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VIRVir Biotechnology Inc
      05/31/20242:42PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VIRVir Biotechnology Inc
      05/29/20244:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VIRVir Biotechnology Inc
      05/29/20244:05PMBusiness WireVir Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:VIRVir Biotechnology Inc
      05/29/20248:05AMBusiness WireVir Biotechnology Appoints Mark Eisner, M.D., M.P.H. as Chief Medical OfficerNASDAQ:VIRVir Biotechnology Inc
      05/23/20244:05PMBusiness WireVir Biotechnology to Host 2024 Annual Meeting of StockholdersNASDAQ:VIRVir Biotechnology Inc
      05/22/20248:05AMBusiness WireMultiple Abstracts Highlighting Vir Biotechnology’s Latest Hepatitis Delta & B Data Accepted for Presentation at the EASL Congress 2024NASDAQ:VIRVir Biotechnology Inc
      05/21/20248:17AMBusiness WireVir Biotechnology Announces SOLSTICE Data to be Featured as an Oral Presentation at the European Association for the Study of the Liver (EASL) Congress 2024NASDAQ:VIRVir Biotechnology Inc
      05/14/20244:05PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:VIRVir Biotechnology Inc
      05/02/20244:05PMBusiness WireVir Biotechnology Provides Corporate Update and Reports First Quarter 2024 Financial ResultsNASDAQ:VIRVir Biotechnology Inc
      04/30/20244:05PMBusiness WireVir Biotechnology to Participate in the BofA Securities Healthcare Conference 2024NASDAQ:VIRVir Biotechnology Inc
      04/18/20248:00AMBusiness WireVir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. to its Board of DirectorsNASDAQ:VIRVir Biotechnology Inc
      04/11/20244:30PMBusiness WireVir Biotechnology to Provide Business Update and Report First Quarter 2024 Financial Results on May 2, 2024NASDAQ:VIRVir Biotechnology Inc
      03/05/20248:05AMBusiness WireVir Biotechnology Completes Enrollment of Phase 2 Chronic Hepatitis Delta SOLSTICE Trial Ahead of ScheduleNASDAQ:VIRVir Biotechnology Inc
      02/26/20247:34PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VIRVir Biotechnology Inc
      02/26/20247:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VIRVir Biotechnology Inc
      02/26/20247:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VIRVir Biotechnology Inc
      02/26/20247:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VIRVir Biotechnology Inc
      02/26/20244:27PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:VIRVir Biotechnology Inc
      02/26/20244:10PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:VIRVir Biotechnology Inc
      02/23/20248:05AMBusiness WireVir Biotechnology to Participate in Upcoming Investor Healthcare ConferencesNASDAQ:VIRVir Biotechnology Inc
      02/22/20244:12PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VIRVir Biotechnology Inc
      02/22/20244:05PMBusiness WireVir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:VIRVir Biotechnology Inc
      02/20/20244:33PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VIRVir Biotechnology Inc
      02/20/20244:30PMBusiness WireVir Biotechnology Announces Dr. Phil Pang Will Step Down as Chief Medical OfficerNASDAQ:VIRVir Biotechnology Inc
       Showing the most relevant articles for your search:NASDAQ:VIR